Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MANS-NRIZ Trial Extension in Hospitalized COVID-19
NCT04959786Phase 3Unknown
- Sponsor
- Mansoura University
- Start
- Apr 2021
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of nitazoxanide, ribavirin, CHILD-IVITAB, zinc in COVID-19 pneumonia, sponsored by Mansoura University. Status: unknown.
02
Drugs
nitazoxanideribavirinCHILD-IVITABzinc
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04959786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04959786.